{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001619856","name":"Caribou Biosciences, Inc.","summary":"Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company developing allogeneic (off-the-shelf) CAR-T cell therapies for hematologic malignancies. Its proprietary chRDNA genome-editing technology enables multiplex editing with high precision. Lead candidates include vispa-cel (anti-CD19, for r/r B-NHL) and CB-011 (anti-BCMA, for r/r multiple myeloma), both in phase 1 clinical trials. The company discontinued CB-012 (anti-CLL-1 for r/r AML) and reduced its workforce by 32% in April 2025.","people":[],"products":[{"name":"Vispacabtagene regedleucel (vispa-cel, formerly CB-010)","type":"platform","description":"Allogeneic anti-CD19 CAR-T cell therapy evaluated in ANTLER phase 1 trial for relapsed or refractory B cell non-Hodgkin lymphoma."},{"name":"CB-011","type":"platform","description":"Allogeneic anti-BCMA CAR-T cell therapy evaluated in CaMMouflage phase 1 trial for relapsed or refractory multiple myeloma."},{"name":"chRDNA genome-editing technology","type":"platform","description":"Proprietary CRISPR hybrid RNA-DNA technology enabling precise multiplex genome editing for allogeneic cell therapy manufacturing."},{"name":"CB-012","type":"platform","description":"Allogeneic anti-CLL-1 CAR-T cell therapy for r/r AML; AMpLify phase 1 trial discontinued in April 2025."}],"partnerships":[{"partner_name":"Memorial Sloan Kettering Cancer Center (MSKCC)","partnership_type":"licensing","description":"Exclusive License Agreement dated November 13, 2020, related to CB-012; terminated effective August 11, 2025 following CB-012 discontinuation.","start_date":null}],"affiliations":[],"origin":{"leaf":"53edadd35bfdc38dc59f7a0fd2f645ea600042eddda4cba18a8fff918390a05e","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d2475e370dfd2d8dfdbc62c5a87d2daf7cfa6a7f1a5a9956020b3ae470496f7c","parent":"d1af7cd6170fc784caf1048a4de92f769a2d4ba261251922f752e1738e48888f","source":"0001619856-26-000008","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}